LYEL Latest Press Releases

-- September 14, 2026 --

Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference Globe Newswire 7:00 AM

-- September 10, 2026 --

Lyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer Globe Newswire 4:05 PM

-- August 6, 2026 --

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026 Globe Newswire 4:05 PM

-- June 25, 2026 --

Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference Globe Newswire 8:00 AM

-- June 12, 2026 --

Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients with Large B-Cell Lymphoma at European Hematology Association 2026 Congress Globe Newswire 12:45 PM

-- June 8, 2026 --

Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion Globe Newswire 6:00 AM

-- June 4, 2026 --

Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress Globe Newswire 4:05 PM

-- June 1, 2026 --

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026 Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes